Background: SB939 is a potent competitive inhibitor of Class 1 and 2 histone deacetylase (HDAC).This study was designed to assess the safety, maximum tolera
Pain in patients with metastatic cancer contributes to increased suffering in those already burdened by their advancing illness.The causes of this pain are
Tumor suppressor genes are often silenced in human cancer; this can occur by transcriptional repression by deacetylation in the promoter regions, mediated b
There is an increasing interest in exploring Artemisinin and its derivatives, clinically used antimalarial drugs, as novel anticancer agents.This presentati
Background: The innovative light-activated drug therapy LitxTM is a cytoreductive treatment that uses light-emitting diodes to activate talaporfin sodium (L